Ildong’s Himmune protein supplement ensures bacteria-blocking measures

2024. 11. 11. 11:36
글자크기 설정 파란원을 좌우로 움직이시면 글자크기가 변경 됩니다.

이 글자크기로 변경됩니다.

(예시) 가장 빠른 뉴스가 있고 다양한 정보, 쌍방향 소통이 숨쉬는 다음뉴스를 만나보세요. 다음뉴스는 국내외 주요이슈와 실시간 속보, 문화생활 및 다양한 분야의 뉴스를 입체적으로 전달하고 있습니다.

(MK database)
Ildong Foodis Co.’s Himmune Protein Balance, a protein supplement, hit 500 billion won in cumulative sales in just four and a half years.

The protein supplement continues to fuel growth at the company’s Chuncheon factory in Gangwon Province.

Covering 30,976 square meters, equivalent to about five soccer fields, the Chuncheon facility comprises two main production units: the powder and sterilization buildings.

In the powder building, protein powder products intended for mixing with water or milk are produced, while the newly constructed sterilization building, completed earlier this year, is focused on manufacturing various protein beverages.

These include Himmune Protein Balance drinks, Himmune Active in six varieties, and Himmune Care Mate.

With strict automation and sterilization protocols to prevent bacterial contamination, the facility is well-suited for high-demand production.

In the sterilization building, the production of Himmune Protein Active Milk is currently in full swing. According to factory manager Park Sung-hoon, demand for this product remains high, with plans to produce around 130,000 units today alone, and 800,000 to 900,000 units over the month.

Maeil Business Newspaper observed the production process on Monday, beginning with the mixing of raw ingredients in purified water.

The protein ingredients are sterilized at ultra-high temperatures exceeding 145 degrees Celsius, a rapid heating method that minimizes nutrient loss by reaching the required temperature in just four to five seconds.

Additionally, the factory produces its own sterile packaging, known as sterilization packs, which involves disinfecting, drying, and shaping film materials before sealing them under heat and pressure.

In 2023, Ildong Foodis reported a total revenue of 248.1 billion won ($178 million), with the Chuncheon facility’s robust production supporting the continued success of the Himmune product line.

Copyright © 매일경제 & mk.co.kr. 무단 전재, 재배포 및 AI학습 이용 금지

이 기사에 대해 어떻게 생각하시나요?